STRADA
STE20-related kinase adapter protein alpha
Also known as: LYK5, NY-BR-96, Stlk, STRAA_HUMAN, STRAD
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7RTN6
- Gene
- STRADA
- Ensembl
- ENSG00000266173
- Chromosome
- 17
- Canonical length
- 431 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
The protein encoded by this gene contains a STE20-like kinase domain, but lacks several residues that are critical for catalytic activity, so it is termed a 'pseudokinase'. The protein forms a heterotrimeric complex with serine/threonine kinase 11 (STK11, also known as LKB1) and the scaffolding protein calcium binding protein 39 (CAB39, also known as MO25). The protein activates STK11 leading to the phosphorylation of both proteins and excluding STK11 from the nucleus. The protein is necessary for STK11-induced G1 cell cycle arrest. A mutation in this gene has been shown to result in polyhydramnios, megalencephaly, and symptomatic epilepsy (PMSE) syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been described but their full-length nature is not known. [provided by RefSeq, Sep 2009]
Canonical amino-acid sequenceUniProt
431 residues, UniProt reviewed canonical sequence.
>Q7RTN6|STRADA
1 MSFLVSKPER IRRWVSEKFI VEGLRDLELF GEQPPGDTRR KTNDASSESI ASFSKQEVMS
61 SFLPEGGCYE LLTVIGKGFE DLMTVNLARY KPTGEYVTVR RINLEACSNE MVTFLQGELH
121 VSKLFNHPNI VPYRATFIAD NELWVVTSFM AYGSAKDLIC THFMDGMNEL AIAYILQGVL
181 KALDYIHHMG YVHRSVKASH ILISVDGKVY LSGLRSNLSM ISHGQRQRVV HDFPKYSVKV
241 LPWLSPEVLQ QNLQGYDAKS DIYSVGITAC ELANGHVPFK DMPATQMLLE KLNGTVPCLL
301 DTSTIPAEEL TMSPSRSVAN SGLSDSLTTS TPRPSNGDSP SHPYHRTFSP HFHHFVEQCL
361 QRNPDARPSA STLLNHSFFK QIKRRASEAL PELLRPVTPI TNFEGSQSQD HSGIFGLVTN
421 LEELEVDDWE FLocalizationUniProt · AlphaFold · HPA
Whether an antibody against STRADA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 47 nTPM
Expression across tissuesHPA
Tissue
- testis: 47 nTPM
- cerebellum: 38 nTPM
- cerebral cortex: 37 nTPM
- spleen: 31 nTPM
- hypothalamus: 31 nTPM
- spinal cord: 31 nTPM
Single-cell type
- oligodendrocytes: 97 nCPM
- microglia: 87 nCPM
- epicardial cells: 84 nCPM
- bergmann glia: 82 nCPM
- ependymal cells: 79 nCPM
- astrocytes: 76 nCPM
Immune cell
- basophil: 19 nTPM
- NK-cell: 17 nTPM
- myeloid DC: 16 nTPM
- plasmacytoid DC: 13 nTPM
- neutrophil: 11 nTPM
- memory CD8 T-cell: 11 nTPM
Brain region
- medulla oblongata: 32 nTPM
- cerebral cortex: 32 nTPM
- basal ganglia: 29 nTPM
- hypothalamus: 28 nTPM
- pons: 28 nTPM
- thalamus: 28 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about STRADA.
Disease | GeneticClinVar
24 pathogenic / likely-pathogenic of 446 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Polyhydramnios, megalencephaly, and symptomatic epilepsy
- Self-limited epilepsy with centrotemporal spikes
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.8
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.49
- DepMap mean gene effect
- -0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- ATP binding
- kinase binding
- protein kinase activator activity
- protein serine/threonine kinase activator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of STRADA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads STRADA as an antibody target. Whether an autoantibody or antibody against STRADA could matter depends on whether native STRADA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
STRADA is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label STRADA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...